These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36430497)

  • 1. Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson's Disease.
    Cervilla-Martínez JF; Rodríguez-Gotor JJ; Wypijewski KJ; Fontán-Lozano Á; Wang T; Santamaría E; Fuller W; Mejías R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes.
    Kim KS; Kim JS; Park JY; Suh YH; Jou I; Joe EH; Park SM
    Hum Mol Genet; 2013 Dec; 22(23):4805-17. PubMed ID: 23847046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases.
    Peng J; Liang D; Zhang Z
    Cell Mol Biol Lett; 2024 Aug; 29(1):108. PubMed ID: 39127627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Cellular Palmitoylation Mitigates α-Synuclein Accumulation and Neurotoxicity.
    Ho GPH; Ramalingam N; Imberdis T; Wilkie EC; Dettmer U; Selkoe DJ
    Mov Disord; 2021 Feb; 36(2):348-359. PubMed ID: 33103814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
    Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA
    Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO-regulated mitochondrial function in Parkinson's disease.
    Guerra de Souza AC; Prediger RD; Cimarosti H
    J Neurochem; 2016 Jun; 137(5):673-86. PubMed ID: 26932327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.
    Thaler A; Kliper E; Maidan I; Herman T; Rosenberg-Katz K; Bregman N; Gurevich T; Shiner T; Hausdorff JM; Orr-Urtreger A; Giladi N; Mirelman A
    Brain Topogr; 2018 Nov; 31(6):1029-1036. PubMed ID: 29846835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia.
    Garcia-Esparcia P; Koneti A; Rodríguez-Oroz MC; Gago B; Del Rio JA; Ferrer I
    Brain Pathol; 2018 Jan; 28(1):43-57. PubMed ID: 27984680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more….
    Rouaud T; Corbillé AG; Leclair-Visonneau L; de Guilhem de Lataillade A; Lionnet A; Preterre C; Damier P; Derkinderen P
    Rev Neurol (Paris); 2021 Mar; 177(3):260-271. PubMed ID: 33032797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.
    Ferrer I
    Prog Neurobiol; 2009 Jun; 88(2):89-103. PubMed ID: 19482226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models for Parkinson's disease.
    Patil DA; Patil VA; Bari SB; Surana SJ; Patil PO
    CNS Neurol Disord Drug Targets; 2014; 13(9):1580-94. PubMed ID: 25106631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death pathways in Parkinson's disease: role of mitochondria.
    Yao Z; Wood NW
    Antioxid Redox Signal; 2009 Sep; 11(9):2135-49. PubMed ID: 19422283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
    Trinh D; Israwi AR; Arathoon LR; Gleave JA; Nash JE
    J Neurochem; 2021 Mar; 156(6):715-752. PubMed ID: 33616931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into Parkinson's disease.
    Rochet JC; Hay BA; Guo M
    Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma Exosomes in Inherited Forms of Parkinson's Disease].
    Kulabukhova DG; Garaeva LA; Emelyanov AK; Senkevich KA; Gracheva EV; Miliukhina IV; Varfolomeeva EY; Timofeeva AA; Schwartsman AL; Shtam TA; Pchelina SN
    Mol Biol (Mosk); 2021; 55(2):338-345. PubMed ID: 33871446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration.
    Shafi S; Singh A; Gupta P; Chawla PA; Fayaz F; Sharma A; Pottoo FH
    CNS Neurol Disord Drug Targets; 2021; 20(1):54-67. PubMed ID: 32885763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial function and cellular energy maintenance during aging in a Drosophila melanogaster model of Parkinson disease.
    Gonçalves DF; Duarte T; Foletto JVP; Senger LR; Barbosa NBV; Soares FAA; Dalla Corte CL
    Mitochondrion; 2022 Jul; 65():166-175. PubMed ID: 35787469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
    Ryan BJ; Hoek S; Fon EA; Wade-Martins R
    Trends Biochem Sci; 2015 Apr; 40(4):200-10. PubMed ID: 25757399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.